FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2062259752> ?p ?o ?g. }

• W2062259752 endingPage "66" @default.
• W2062259752 startingPage "61" @default.
• W2062259752 abstract "Gallego S, Llort A, Gros L, Sanchez de Toledo Jr J, Bueno J, Moreno A, Nieto J, Sanchez de Toledo J. Post-transplant lymphoproliferative disorders in children: The role of chemotherapy in the era of rituximab.Pediatr Transplantation 2010: 14: 61–66. © 2009 John Wiley & Sons A/S. Abstract: PTLD are the most frequent neoplasms in children postorgan transplantation. We describe our experience in the treatment of 14 children (three with early and 11 with late-onset disease) treated with a step-wise protocol developed at our institution. Treatment consisted of reducing immunosuppressants, followed by rituximab and chemotherapy if required. Rituximab, incorporated into the protocol in 2001, has been determinant for the total chemotherapy burden patients need to achieve remission. In seven patients who did not receive rituximab, anthracycline total dose ranged from 160 to 240 mg/m2, while only one of the patients receiving rituximab required DOXO (range: 0–120 mg/m2) (p = 0.003). The use of alkylating agents was also notably lower in patients receiving rituximab (median dose = 1200 mg/m2) compared with those who did not receive rituximab (median dose = 5800 mg/m2) (p = 0.006). Twelve patients are in remission and two died, one from refractory disease and the other from septic shock. Two-year OS and EFS were 85.7% and 57%, respectively. In conclusion, our experience with the use of rituximab in children with PTLD after solid organ transplantation appeared to be associated with a lesser requirement for alkylating agents and anthracyclines compared with historical subjects, suggesting a reduction in the side effects of these agents." @default.
• W2062259752 created "2016-06-24" @default.
• W2062259752 creator A5008878915 @default.
• W2062259752 creator A5040945939 @default.
• W2062259752 creator A5043262349 @default.
• W2062259752 creator A5054011024 @default.
• W2062259752 creator A5068642020 @default.
• W2062259752 creator A5081138628 @default.
• W2062259752 creator A5085463132 @default.
• W2062259752 date "2010-02-01" @default.
• W2062259752 modified "2023-10-16" @default.
• W2062259752 title "Post-transplant lymphoproliferative disorders in children: The role of chemotherapy in the era of rituximab" @default.
• W2062259752 cites W1484652234 @default.
• W2062259752 cites W1543833158 @default.
• W2062259752 cites W1989980624 @default.
• W2062259752 cites W2002348226 @default.
• W2062259752 cites W2007490446 @default.
• W2062259752 cites W2008200942 @default.
• W2062259752 cites W2028889698 @default.
• W2062259752 cites W2029047968 @default.
• W2062259752 cites W2031832264 @default.
• W2062259752 cites W2034912420 @default.
• W2062259752 cites W2035328957 @default.
• W2062259752 cites W2040452703 @default.
• W2062259752 cites W2052038595 @default.
• W2062259752 cites W2054074393 @default.
• W2062259752 cites W2060853845 @default.
• W2062259752 cites W2084795750 @default.
• W2062259752 cites W2089377513 @default.
• W2062259752 cites W2135455909 @default.
• W2062259752 cites W2137858837 @default.
• W2062259752 cites W2143068491 @default.
• W2062259752 cites W2147556291 @default.
• W2062259752 cites W2156073127 @default.
• W2062259752 cites W2156902794 @default.
• W2062259752 cites W2156997556 @default.
• W2062259752 cites W2159424016 @default.
• W2062259752 cites W2168740454 @default.
• W2062259752 cites W2168772082 @default.
• W2062259752 doi "https://doi.org/10.1111/j.1399-3046.2009.01181.x" @default.
• W2062259752 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19344338" @default.
• W2062259752 hasPublicationYear "2010" @default.
• W2062259752 type Work @default.
• W2062259752 sameAs 2062259752 @default.
• W2062259752 citedByCount "23" @default.
• W2062259752 countsByYear W20622597522012 @default.
• W2062259752 countsByYear W20622597522014 @default.
• W2062259752 countsByYear W20622597522015 @default.
• W2062259752 countsByYear W20622597522016 @default.
• W2062259752 countsByYear W20622597522017 @default.
• W2062259752 countsByYear W20622597522018 @default.
• W2062259752 countsByYear W20622597522019 @default.
• W2062259752 countsByYear W20622597522020 @default.
• W2062259752 countsByYear W20622597522022 @default.
• W2062259752 crossrefType "journal-article" @default.
• W2062259752 hasAuthorship W2062259752A5008878915 @default.
• W2062259752 hasAuthorship W2062259752A5040945939 @default.
• W2062259752 hasAuthorship W2062259752A5043262349 @default.
• W2062259752 hasAuthorship W2062259752A5054011024 @default.
• W2062259752 hasAuthorship W2062259752A5068642020 @default.
• W2062259752 hasAuthorship W2062259752A5081138628 @default.
• W2062259752 hasAuthorship W2062259752A5085463132 @default.
• W2062259752 hasConcept C121332964 @default.
• W2062259752 hasConcept C126322002 @default.
• W2062259752 hasConcept C141071460 @default.
• W2062259752 hasConcept C142424586 @default.
• W2062259752 hasConcept C168444539 @default.
• W2062259752 hasConcept C2776694085 @default.
• W2062259752 hasConcept C2776995267 @default.
• W2062259752 hasConcept C2779338263 @default.
• W2062259752 hasConcept C2780653079 @default.
• W2062259752 hasConcept C2911091166 @default.
• W2062259752 hasConcept C71924100 @default.
• W2062259752 hasConcept C87355193 @default.
• W2062259752 hasConcept C90924648 @default.
• W2062259752 hasConceptScore W2062259752C121332964 @default.
• W2062259752 hasConceptScore W2062259752C126322002 @default.
• W2062259752 hasConceptScore W2062259752C141071460 @default.
• W2062259752 hasConceptScore W2062259752C142424586 @default.
• W2062259752 hasConceptScore W2062259752C168444539 @default.
• W2062259752 hasConceptScore W2062259752C2776694085 @default.
• W2062259752 hasConceptScore W2062259752C2776995267 @default.
• W2062259752 hasConceptScore W2062259752C2779338263 @default.
• W2062259752 hasConceptScore W2062259752C2780653079 @default.
• W2062259752 hasConceptScore W2062259752C2911091166 @default.
• W2062259752 hasConceptScore W2062259752C71924100 @default.
• W2062259752 hasConceptScore W2062259752C87355193 @default.
• W2062259752 hasConceptScore W2062259752C90924648 @default.
• W2062259752 hasIssue "1" @default.
• W2062259752 hasLocation W20622597521 @default.
• W2062259752 hasLocation W20622597522 @default.
• W2062259752 hasOpenAccess W2062259752 @default.
• W2062259752 hasPrimaryLocation W20622597521 @default.
• W2062259752 hasRelatedWork W1975033056 @default.
• W2062259752 hasRelatedWork W1983005038 @default.
• W2062259752 hasRelatedWork W2080180985 @default.
• W2062259752 hasRelatedWork W2095227078 @default.
• W2062259752 hasRelatedWork W2134306104 @default.

• next